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Abstract: Crohn´s disease is a multisystem chronic granulomatous inflammatory disease that primarily affects
the gastrointestinal tract. In the majority of the cases, the cutaneous manifestations follow the intestinal disease,
but occasionally dermatological lesions are the inaugural event and may constitute the only sign of the disease.
Vulvoperineal involvement is rare, may precede bowel symptoms by months to years and may go unrecognized.
Due to the paucity of reports of Crohn´s disease at this location and in the absence of randomized trials, there are
no standard treatments for the cutaneous disease. We describe the case of a 47 year-old woman with vulvope-
rineal Crohn´s disease without digestive involvement, that was successfully managed with metronidazole.
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Resumo: A doença de Crohn é uma doença granulomatosa multissistêmica inflamatória crónica que afecta pri-
mariamente o tracto gastrointestinal. Na maioria dos casos, as manifestações cutâneas sucedem a doença intesti-
nal, mas, ocasionalmente, as lesões dermatológicas são o primeiro evento e podem constituir o único sinal da
doença. O envolvimento vulvoperineal é raro, pode preceder os sintomas intestinais em meses ou anos, e pode
passar despercebido. Devido à escassez de relatos de doença de Crohn com esta localização e na ausência de
ensaios clínicos randomizados, não há nenhum tratamento padrão para a doença cutânea. Descrevemos um caso
de uma mulher de 47 anos com doença de Crohn vulvoperineal sem envolvimento digestivo, que foi tratada com
sucesso com metronidazol.
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INTRODUCTION
Crohn´s disease is a multisystem chronic gran-
ulomatous inflammatory disease that primarily
affects the gastrointestinal tract. In the majority of
cases, cutaneous manifestations follow the intestinal
disease, but occasionally dermatological lesions are
the inaugural event and may constitute the only sign
of the disease. Vulvoperineal involvement is rare, may
precede bowel symptoms by months to years and
may go unrecognized. Due to the paucity of reports of
Crohn´s disease at this location and in the absence of
randomized trials, there are no standard treatments
for the cutaneous disease. Numerous therapies
(including surgery, use of antibiotics and immunosup-
pression) have been used with variable results. There
are only anecdotal reports that support the use of
metronidazole. We describe a case of a 47 year-old
woman with vulvoperineal Crohn´s disease without
digestive involvement that was successfully managed
with metronidazole and without side effects. Oral
metronidazole seems to be effective in the treatment
of vulvoperineal Crohn´s disease and cutaneous flares
also respond rapidly to repeated treatment.
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CASE REPORT
A 47-year-old woman presented for evaluation
of multiple persistent painful vulvoperineal lesions
that had appeared in the last 5 years. She went on sev-
eral antibiotic courses without any improvement. She
denied bowel complaints or weight loss. Her past
medical history was only remarkable for hyperten-
sion. On physical examination, an exuberant inflam-
mation of the vulva with aftoid ulcers of the labia
minor and majora, and linear ulcerations in the
inguinocrural folds were observed. A deep linear fis-
sure above the clitoris and a “knife-cut” ulcer with
sharp margins on the buttocks fold were also present
(Figure 1). A skin biopsy revealed an ulcerated epider-
mis with a fistulous tract and aspects of chronic
inflammation with lymphocytes, hystiocytes and
multinucleated giant cells in a non- caseating granulo-
matous pattern on the dermis (Figure 2). Fungal and
mycobacterial elements were not detected by histol-
ogy or in tissue culture. Laboratory investigations
were normal except for C-reactive protein of 41 mg/dl
(<5). Syphilis, HIV serologies and Mantoux test were
negative.  PCR testing for herpes simplex virus was
negative. Chest X-ray showed no abnormalities.
Based on the clinical and histological findings a vul-
voperineal cutaneous Crohn´s disease (CD) diagnosis
was made. The patient was referred to gastroenterolo-
gy for evaluation of bowel involvement. Endoscopic
studies of the digestive tract and biopsies from the
ileum, colon and rectum showed no abnormalities, so
that a diagnosis of vulvoperineal cutaneous CD with-
out digestive involvement was assumed. The patient
went on daily metronidazole (1000 mg) and
ciprofloxacin (1000 mg) with a striking improvement.
Antibiotherapy was discontinued at 3 months and
azathioprine (50 mg daily) was introduced. However,
the condition worsened and metronidazole (1000 mg
daily) was added to azathioprine and marked
improvement was observed after 12 days. At 2 months
of combined therapy (metronidazole 1000 mg plus
azathioprine 150 mg daily) sustained clinical
improvement was observed (Figure 3).
FIGURE 1: Clinical fin-
dings at presentation
FIGURE 2: H&E (10x):
ulcerated epidermis
with a fistulous tract
(left). PAS (40x):
aspects of chronic
inflammation in a
granulomatous pat-
tern in the dermis
(right)
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FIGURE 3:
Clinical impro-
vement with
metronidazole
and azathioprine
at 2 months of
therapy
DISCUSSION
In CD the mucocutaneous lesions usually fol-
low the intestinal disease and exceptionally occur
prior to bowel involvement.1 In the latter case, a high
index of suspicion may be required to reach the accu-
rate diagnosis. Most of the lesions are a result of direct
extension of the intestinal disease (perineal abscesses
and fistula) and more rarely they occur in a noncon-
tiguous extraintestinal spread (metastatic CD).
Genitalia involvement in CD is rare.2,3 Andreani  et al,
reported that 25% of vulvar CD did not have any pre-
vious intestinal symptoms and patients had not been
diagnosed as having CD.2 Vulvar swelling, erythema
and pain that evolve to vulvar hypertrophy, ulceration
and abscesses are the typical clinical picture. “Knife-
cut” ulcers (as in our case) are almost pathognomonic
of CD, although they have been described in cuta-
neous tuberculosis and herpetic infections in
immunocompromised patients.3 The histological
examination characteristically shows non-caseating
granulomas. The differential diagnoses include other
granulomatous diseases that can cause vulvar ulcera-
tion  such as sarcoidosis, tuberculosis, fungal infec-
tions,  lymphogranuloma venereum, granuloma
inguinale and actinomycosis. Sometimes pyoderma
gangrenosum can clinically mimic cutaneous Crohn´s
disease. Ruling out infections usually requires bacteri-
ological and mycological workup. Due to a paucity of
reports with this topography the treatment remains
nonstandardized.4 Several medical treatments for
cutaneous disease have been proposed with variable
results and include: topical, intralesional and systemic
corticosteroids, sulfasalazine, azathioprine,
cyclosporine, methotrexate, thalidomide, metronida-
zole, infliximab, adalimumab and surgical excision.
Only few small studies and anecdotal reports have
evaluated the use of metronidazole.2,3,4-7 As supported
by our case, it seems to be effective with resolution of
almost all the lesions. In combination with oral corti-
cotherapy a success rate of 87.5% has been
reported.2 Its efficacy is probably due to its anti-
inflammatory, antibacterial and immunosuppressive
action.4 In the study of Brandt LJ et al, the lesions of all
26 patients with perineal CD cleared, and an optimal
dose of 20 mg/kg/day for 12 to 36 months was
required.8 The tapering of this dose often leads to
recurrences, however cutaneous lesions promptly
respond to repeated treatment with the
drug.5,8 Reversible paresthesia is the major complica-
tion reported with long-term metronidazole thera-
py.4 Minor complications include a metallic taste and
darkening of the urine together with gastrointestinal
upset. In our patient the treatment was well-tolerated
without any side effects. We report an extremely atyp-
ical presentation of CD that was successfully managed
with metronidazole with no significant adverse
effects. Physicians should be aware of such presenta-
tion as it may precede gastrointestinal involvement
and be a cause of high morbidity if not promptly rec-
ognized. q
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